Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Facet-Joint Injection Market from 2024 to 2025?

The market size for facet-joint injections has seen significant growth recently. Projected increases show it going from $2.78 billion in 2024 to $2.97 billion in 2025, boasting a compound annual growth rate (CAGR) of 7.0%. Factors contributing to growth in the past include an increase in chronic back and neck pain incidents, a growing preference for minimally invasive pain management treatments, an increasing elderly demographic suffering from spinal degeneration, enhanced availability of image-guided injection procedures, and heightened awareness concerning non-surgical options for pain relief.

What Is the Projected Market Size of the Facet-Joint Injection Market?

In the coming years, the market size for facet-joint injections is projected to experience significant growth, reaching a value of $3.85 billion in 2029, with a compound annual growth rate (CAGR) of 6.7%. This predicted growth during the forecast period can be ascribed to factors such as the increasing demand for non-opioid alternatives for pain management, the surge in acceptance of image-guided injection technologies, elevated attention on outpatient and day-care surgical approaches, wider application of regenerative injection therapies, and boosted healthcare investments into therapies for spinal disorders. Key trends projected for the forecast period include the improvement in ultrasound and fluoroscopy-guided injections, the creation of advanced drug formulations for extended pain management, combination therapy developments for joint pain, the invention of innovative regenerative treatments like platelet-rich plasma and stem cells, and progress in wearable technology for monitoring after injections.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24531&type=smp

Who are the Major Competitors in the Facet-Joint Injection Market Outlook?

Major companies operating in the facet-joint injection market are Pfizer Inc., Merck & Co. Inc, AbbVie Inc., Sanofi S.A., Medtronic plc, Stryker Corporation, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Henry Schein Inc., Bausch Health Companies Inc., Zimmer Biomet Holdings Inc., Smith & Nephew plc, Dr. Reddy’s Laboratories Ltd., Arthrex Inc., Aspen Pharmacare Holdings Limited, Pacira BioSciences Inc., Bioventus Inc., Ferring Pharmaceuticals, Anika Therapeutics Inc., Symbiotec Pharmalab Pvt. Ltd.

What Is Fueling Growth in the Facet-Joint Injection Market?

The spike in spinal diseases and chronic back pain instances is set to fuel the expansion of the facet-joint injection market in the future. Spinal diseases and chronic back pain are long-standing conditions affecting the spine, such as arthritis or nerve compression, that result in persistent discomfort, limited mobility, and diminished quality of life. These conditions, triggered by sedentary lifestyles and poor posture habits, have individuals in search of effective treatments that mitigate consistent discomfort and restore functional movement. Facet-joint injections offer a solution for these conditions by lessening the pain and inflammation in the spine. It also provides relief for people enduring the increasing issue of spinal diseases and chronic back pain. For example, Spinal Cord Inc., a non-profit resource center based in the US, reported approximately 18,000 new spinal cord injury cases annually in the United States in May 2023, with an estimated 302,000 individuals nationwide currently suffering from spinal cord injuries. As a result, the facet-joint injection market is seeing growth due to the spike in spinal diseases and chronic back pain. The augmenting demand for minimally invasive procedures is projected to fuel the expansion of the facet-joint injection market. These procedures are medical interventions that are performed through small incisions or without a need for large surgical cuts. The mounting preference amongst patients for quicker recovery periods and less post-operation pain is driving the increase in minimally invasive procedures. Facet-joint injections contribute to the growth of these procedures by offering targeted pain relief and precise diagnosis without the need for major surgical intervention. For instance, according to the American Society of Plastic Surgeons, a specialty organization based in the US, the total number of minimally invasive cosmetic procedures surged from 23.7 million in 2022 to 25.4 million in 2023. Therefore, the facet-joint injection market is seeing growth due to the increasing demand for minimally invasive procedures.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24531&type=smp

Which Facet-Joint Injection Market Segments Are Growing the Fastest?

The facet-joint injection market covered in this report is segmented –

1) By Product Type: Corticosteroids, Local Anesthetics, Hyaluronic Acid, Other Product Types

2) By Application: Cervical Facet Joints, Thoracic Facet Joints, Lumbar Facet Joints, Facet Joint Injections

3) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users

Subsegments:

1) By Corticosteroids: Triamcinolone Acetonide, Methylprednisolone Acetate, Dexamethasone Sodium Phosphate, Betamethasone, Other Corticosteroids

2) By Local Anesthetics: Lidocaine, Bupivacaine, Ropivacaine, Prilocaine, Other Local Anesthetics

3) By Hyaluronic Acid: High Molecular Weight Hyaluronic Acid, Low Molecular Weight Hyaluronic Acid, Cross-Linked Hyaluronic Acid, Non-Cross-Linked Hyaluronic Acid

4) By Other Product Types: Platelet-Rich Plasma, Biological Agents, Combination Formulations, Other Injectables

Which Industry Trends Are Shaping the Future of the Facet-Joint Injection Market?

Main players in the industry of facet-joint injection are investing in the development of advanced products, for instance, facet fusion systems, in order to extend the relief duration and boost the results of treatment. Facet fusion systems are a type of medical apparatus created to stabilize and merge the facet joints of the spine, encouraging the growth of bone between adjacent vertebrae. Take for example in March 2025, when Aurora Spine Corporation, a medical device organization based in the United States, reported that their latest product the AEROTM Facet Fusion System, obtained 510(k) clearance from the FDA. The system incorporates a titanium plasma spray coating to enhance osseointegration and increase fusion potential. With a range of implant sizes to suit various patient anatomies, along with radiolucent instrumentation for better visibility during surgery, the system aims to augment procedural efficiency and long-term results for patients dealing with chronic back pain due to facet joint complications.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/facet-joint-injection-global-market-report

Which Countries Are Leading the Facet-Joint Injection Market?

North America was the largest region in the facet-joint injection market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the facet-joint injection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24531

This Report Delivers Insight On:

1. How big is the facet-joint injection market, and how is it changing globally?

2. Who are the major companies in the facet-joint injection market, and how are they performing?

3. What are the key opportunities and risks in the facet-joint injection market right now?

4. Which products or customer segments are growing the most in the facet-joint injection market?

5. What factors are helping or slowing down the growth of the facet-joint injection market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model